WSTAM
AVDL

Wilbanks Smith & Thomas Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-240
Closed -$1K – 424
2018
Q3 		$1K Buy
+240
New +$1K ﹤0.01% 1488